XML 94 R77.htm IDEA: XBRL DOCUMENT
v3.22.1

Long-Term Investments (Details) - Schedule of ownership percentages of investee | 3 Months Ended | 12 Months Ended |
--- | --- | --- | ---
Mar. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Braingenesis Biotechnology Co., Ltd. [Member] |  |  |
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items] |  |  |
Ownership percentage | 0.17% | 0.17% | 0.17%
Accounting treatments | Cost Method | Cost Method |
Genepharm Biotech Corporation [Member] |  |  |
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items] |  |  |
Ownership percentage | 0.70% | 0.70% | 0.70%
Accounting treatments | Cost Method | Cost Method |
BioHopeKing Corporation [Member] |  |  |
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items] |  |  |
Ownership percentage | 5.90% | 5.90% | 5.90%
Accounting treatments | Cost Method | Cost Method |
BioFirst Corporation [Member] |  |  |
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items] |  |  |
Ownership percentage | 15.99% | 15.99% | 15.99%
Accounting treatments | Equity Method | Equity Method |
Rgene Corporation [Member] |  |  |
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items] |  |  |
Ownership percentage | 31.62% | 31.62% | 31.62%
Accounting treatments | Equity Method | Equity Method |

X
- References No definition available. + Details
Name: | abvc_AccountingTreatmentDescription
Namespace Prefix: | abvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | abvc_LongTermInvestmentsDetailsScheduleofownershippercentagesofinvesteeLineItems
Namespace Prefix: | abvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_GenepharmBiotechCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvc_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |